BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11810790)

  • 1. [Failed azithromycin treatment of Chlamydia trachomatis infection].
    Andersen SE; Jürgens G; Dalhoff KP
    Ugeskr Laeger; 2001 Dec; 164(1):17. PubMed ID: 11810790
    [No Abstract]   [Full Text] [Related]  

  • 2. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago.
    Swanston WH; Prabhakar P; Barrow L; Mahabir BS; Furlonge C
    West Indian Med J; 2001 Sep; 50(3):198-202. PubMed ID: 11769023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which treatment for genital tract Chlamydia trachomatis infection?
    Tobin JM; Harindra V; Mani R
    Int J STD AIDS; 2004 Nov; 15(11):737-9. PubMed ID: 15537459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.
    Renault CA; Israelski DM; Levy V; Fujikawa BK; Kellogg TA; Klausner JD
    Sex Health; 2011 Mar; 8(1):69-73. PubMed ID: 21371385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy.
    Horner PJ
    Sex Transm Infect; 2012 Apr; 88(3):154-6. PubMed ID: 22416272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in the treatment of Chlamydia trachomatis infection].
    Shi LL; Lu JC; Huangfu YM
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):296-8. PubMed ID: 15921264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
    Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
    J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Questioning azithromycin for chlamydial infection.
    Handsfield HH
    Sex Transm Dis; 2011 Nov; 38(11):1028-9. PubMed ID: 21992978
    [No Abstract]   [Full Text] [Related]  

  • 10. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection.
    Horner P
    Sex Transm Infect; 2006 Aug; 82(4):340-3. PubMed ID: 16877590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin.
    Wyrick PB; Knight ST
    J Antimicrob Chemother; 2004 Jul; 54(1):79-85. PubMed ID: 15163653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.
    Smelov V; Krylova T; Smelova N; Norman L
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S79-82. PubMed ID: 15037332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronucleus frequency in women with genital Chlamydia Trachomatis infection before and after therapy.
    Dimitrijević A; Milosević-Djordjević O; Grujicić D; Arsenijević S
    Mutat Res; 2006 Sep; 608(1):43-8. PubMed ID: 16777475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.
    Skerk V; Krhen I; Lisić M; Begovac J; Roglić S; Skerk V; Sternak SL; Banaszak A; Strugar-Suica J; Vuković J
    Int J Antimicrob Agents; 2004 Aug; 24(2):188-91. PubMed ID: 15288321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
    Manavi K; Hettiarachchi N; Hodson J
    Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the most appropriate treatment for rectal Chlamydia trachomatis infection?
    Hathorn E; Ward D; Goold P
    Sex Transm Infect; 2016 Mar; 92(2):115. PubMed ID: 26892930
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
    Bhengraj AR; Srivastava P; Mittal A
    Int J Antimicrob Agents; 2011 Aug; 38(2):178-9. PubMed ID: 21570258
    [No Abstract]   [Full Text] [Related]  

  • 19. Five-day Azithromycin Treatment Regimen for Mycoplasma genitalium Infection Also Effectively Eradicates Chlamydia trachomatis.
    Unemo M; Endre KM; Moi H
    Acta Derm Venereol; 2015 Jul; 95(6):730-2. PubMed ID: 25823977
    [No Abstract]   [Full Text] [Related]  

  • 20. [Should azithromycin dosing be changed?].
    Nilsen E
    Tidsskr Nor Laegeforen; 2011 Aug; 131(15):1415. PubMed ID: 21844939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.